Groups hail Alzheimer's drug U-turn by health watchdog

Hundreds of thousands more patients in the early stages of Alzheimer's disease could get drug treatments following a U-turn by the health watchdog.

The National Institute for Health and Clinical Excellence, covering England and Wales, now says evidence backs the use of drugs for "mild" symptoms.

Jane Hughes reports.